Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.1 USD | +1.62% | -1.71% | -25.31% |
11:30am | Legend Expects to Log Profit in 2026 | MT |
14/05 | HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.31% | 8.09B | |
+6.14% | 111B | |
+12.04% | 106B | |
-12.47% | 22.24B | |
-1.16% | 21.25B | |
-4.97% | 18.97B | |
-35.21% | 18.52B | |
-10.44% | 16.81B | |
+38.81% | 12.54B | |
+306.56% | 7.99B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- BMO Capital Adjusts Price Target on Legend Biotech to $90 From $79, Maintains Outperform Rating